We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+6.2%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$9.56B
AUM Growth
+$531M
(+5.9%)
Cap. Flow
+$49.6M
Cap. Flow
% of AUM
0.52%
Top 10 Holdings %
Top 10 Hldgs %
14.04%
Holding
1,755
New
15
Increased
420
Reduced
1,119
Closed
198
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
General Dynamics
GD
|
+$57.1M |
| 2 |
Federal Realty Investment Trust
FRT
|
+$54.9M |
| 3 |
New Jersey Resources
NJR
|
+$10.3M |
| 4 |
Medtronic
MDT
|
+$10.1M |
| 5 |
UMB Financial
UMBF
|
+$10M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Healthpeak Properties
DOC
|
+$48.2M |
| 2 |
CLC
Clarcor
CLC
|
+$15.4M |
| 3 |
Amgen
AMGN
|
+$11.3M |
| 4 |
Apple
AAPL
|
+$9.79M |
| 5 |
Nucor
NUE
|
+$8.91M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.52% |
| 2 | Healthcare | 14.53% |
| 3 | Technology | 12.08% |
| 4 | Consumer Staples | 11.47% |
| 5 | Industrials | 10.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Mueller Water Products
MWA
$3.93B
| $212K | ﹤0.01% |
17,948
-7,096
| -28% | -$90.1K |
|
1427
Enpro
NPO
$7.17B
| $212K | ﹤0.01% |
2,983
-960
| -24% | -$63.6K |
|
1428
Azenta
AZTA
$1.27B
| $211K | ﹤0.01% |
9,439
-3,010
| -24% | -$59.7K |
|
1429
Exponent
EXPO
$2.97B
| $211K | ﹤0.01% |
7,080
-2,276
| -24% | -$66.3K |
|
|
KW
1430
DELISTED
Kennedy-Wilson Holdings
KW
| $211K | ﹤0.01% |
9,497
-3,757
| -28% | -$79.1K |
|
|
AVDL
1431
DELISTED
Avadel Pharmaceuticals
AVDL
| $209K | ﹤0.01% |
21,579
-5,078
| -19% | -$50.8K |
|
1432
Neurogene
NGNE
$691M
| $209K | ﹤0.01% |
625
-149
| -19% | -$52.3K |
|
|
MIK
1433
DELISTED
Michaels Stores, Inc
MIK
| $209K | ﹤0.01% |
+9,338
| New | +$196K |
|
|
BOLD
1434
DELISTED
Audentes Therapeutics, Inc
BOLD
| $209K | ﹤0.01% |
12,257
-3,020
| -20% | -$48.8K |
|
|
EBIX
1435
DELISTED
Ebix Inc
EBIX
| $209K | ﹤0.01% |
3,408
-1,138
| -25% | -$67.6K |
|
1436
Towne Bank
TOWN
$3.34B
| $208K | ﹤0.01% |
6,434
-2,545
| -28% | -$82.5K |
|
|
BLCM
1437
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $208K | ﹤0.01% |
1,688
-440
| -21% | -$57.6K |
|
|
CORE
1438
DELISTED
Core Mark Holding Co., Inc.
CORE
| $206K | ﹤0.01% |
6,601
-1,957
| -23% | -$68.4K |
|
|
DCH
1439
Dauch Corp
DCH
$1.32B
| $205K | ﹤0.01% |
10,900
-3,427
| -24% | -$68.4K |
|
1440
Designer Brands
DBI
$280M
| $205K | ﹤0.01% |
9,903
-1,467
| -13% | -$30.4K |
|
1441
ESCO Technologies
ESE
$8.55B
| $205K | ﹤0.01% |
3,524
-1,129
| -24% | -$63.4K |
|
1442
Fabrinet
FN
$17.5B
| $205K | ﹤0.01% |
4,874
-1,547
| -24% | -$64.3K |
|
|
CCXI
1443
DELISTED
ChemoCentryx, Inc.
CCXI
| $205K | ﹤0.01% |
28,164
-7,114
| -20% | -$51.2K |
|
|
OMED
1444
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $205K | ﹤0.01% |
22,240
-5,673
| -20% | -$49.8K |
|
|
GOV
1445
DELISTED
Government Properties Income Trust
GOV
| $204K | ﹤0.01% |
9,728
-3,121
| -24% | -$62.2K |
|
|
VISN
1446
Vistance Networks Inc
VISN
$2.68B
| $203K | ﹤0.01% |
+4,867
| New | +$187K |
|
|
SEM
1447
DELISTED
Select Medical
SEM
| $203K | ﹤0.01% |
28,282
-9,012
| -24% | -$65.3K |
|
1448
Ambarella
AMBA
$2.97B
| $202K | ﹤0.01% |
3,686
-1,458
| -28% | -$78.7K |
|
1449
Omnicell
OMCL
$1.85B
| $202K | ﹤0.01% |
4,958
-1,572
| -24% | -$57.9K |
|
1450
HubSpot
HUBS
$10.2B
| $201K | ﹤0.01% |
3,323
-1,314
| -28% | -$74.4K |
|
Similar funds
ProShare Advisors's Q1 2017 Portfolio in Review
As of Q1 2017, ProShare Advisors held 1,755 positions worth $9.56B, up 5.9% from $9.03B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
ProShare Advisors's Q1 2017 filing shows 15 new, 420 increased, 1,119 reduced and 198 closed positions. Its largest new stake was Qiagen: 113,675 shares worth $3.49M. The largest sale was Healthpeak Properties, an estimated $48.2M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.
- ProShare Advisors's largest Q1 2017 buy was Qiagen: 113,675 shares worth $3.49M.
- ProShare Advisors added most to General Dynamics in Q1 2017, an estimated $57.1M increase.
- ProShare Advisors's biggest Q1 2017 reduction was Healthpeak Properties, cutting an estimated $48.2M.
- ProShare Advisors fully exited Clarcor in Q1 2017, selling an estimated $15.4M.
- ProShare Advisors's ten largest holdings make up 14% of its $9.56B portfolio in Q1 2017.
- ProShare Advisors opened 15 new positions and closed 198 in Q1 2017.
- ProShare Advisors's portfolio value rose 5.9% quarter-over-quarter to $9.56B.
Based on ProShare Advisors's 13F filing for Q1 2017, filed 25 Apr 2017.